Pidotimod impurity Y


We Guarantee Best Price for this compound*
If you get a better price we will match the same.
Product Details

CAT No.# CS-AQ-00006
Category Impurities
CAS 161771-76-2
Molecular Weight 226.25
Molecular Formula C9H10N2O3S
Stock Status: In-Stock
Purity: >98%
Synonyms: Pidotimod impurity Y;Pidotimod Diketopiperazine Dihydro-1H,3H,5H-pyrrolo[1,2- a]thiazolo[3,4-d]pyrazine- 5,8,10(5ah,10ah)-trione;Dihydro-1H,5H-pyrrolo[1,2-a][1,3]thiazolo[3,4-d]pyrazine-5,8,10(5aH,10aH)-trione;Dihydro-1H,5H-pyrrolo[1,2-a][1,3]thiazolo[3,4-d]pyrazine-5,8,10(5aH,10aH)-trione;1H,3H,5H-Pyrrolo[1,2-a]thiazolo[3,4-d]pyrazine-5,8,10(5aH,10aH)-trione, dihydro- .
Application Notes: Impurity in commercial preparation of Pidotimod.
Shipping: Free Shipping for worldwide on order above 2000 USD
COA:    View COA
Pidotimod impurity Y Worldwide Suppliers of Pidotimod impurity Y Impurities Clearsynth CS-AQ-00006

Product rating: 9 Pidotimod impurity Y based on 20 ratings

  1. Impurities
  2. Pidotimod impurity Y

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Nandrolone Decanoate EP impurity F
15. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline
16. Ortho toluene sulfonic acid
17. Sucrose (1623637)
18. Crisaborole m-Isomer
19. Riluzole (1604337)
20. Pheniramine impurity B


This page contains information about Pidotimod impurity Y Cas 161771-76-2 and its Impurities.

Pidotimod impurity Y Pidotimod impurity Y Worldwide Suppliers of Pidotimod impurity Y Impurities Clearsynth 161771-76-2

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."